Name:
Dr Rebecca Muirhead
Post-nominal Letters:
MBChB MRCP MD FRCR
Job Title:
Consultant Clinical Oncologist
Organisation / Company:
Oxford University Hospitals
Biography:
Rebecca led the national implementation of Anal and Rectal IMRT which are now routinely delivered across the UK and the gold standard within prospective trials. As deputy chair of the UK SABR Consortium she has led the development of national pelvic SABR reirradiation guidelines and is leading the national audit of this technique. Her research interests are personalised radiotherapy and reirradiation. She is currently a member of the ESTRO Reirradiation Focus Group and the ReCOG Lower GI reirradiation Group. She is a CI, co-CI, TMG or DMEC member, RTTQA reviewer or safety committee member for a number of UK trials such as ART, PLATO, CEDAR, PRIME, HALT, ELECTRA. She has over 50 peer reviewed articles published in international journals which can be reviewed at: